Enhancing diagnosis and treatment of rectal cancer

The Biomarkers Substudy of the
TiMiSNAR Trial

TiMiSNAR Trial

TIMING TO MINIMALLY INVASIVE SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR RECTAL CANCER: A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Find more
Protocol paper published on BMC Trials

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer. TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). Protocol Paper.